Related Experiment Video
Updated: Jul 22, 2026
10:03
Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
The effect of seromucoid on coagulation
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|September 12, 1981
Summary
Alpha-acid-glycoprotein, an acute-phase reactant, significantly impacts blood coagulation by shortening partial thromboplastin time (PTT). This protein may play a role in coagulation disorders associated with cancer.
Area of Science:
- Biochemistry
- Hematology
- Oncology
Background:
- Alpha-acid-glycoprotein is an acute-phase reactant with elevated blood levels in malignant diseases and acute conditions.
- Investigating its role in coagulation is crucial for understanding disease-related hemostatic changes.
Purpose of the Study:
- To investigate the effect of alpha-acid-glycoprotein on blood coagulation.
- To compare alpha-acid-glycoprotein isolated from serum versus plasma.
Main Methods:
- Isolation of alpha-acid-glycoprotein from normal human serum and plasma.
- Determination of protein yield and molecular weight.
- Assessment of coagulation parameters, including partial thromboplastin time (PTT) and prothrombin index.
- Evaluation of the interaction with heparin's anticoagulant activity.
Main Results:
- Higher yield of alpha-acid-glycoprotein from serum (43 mg/dl) compared to plasma (22 mg/dl).
- Distinct molecular weights for serum (55,000 Da) and plasma (81,000 Da) preparations.
- Alpha-acid-glycoprotein significantly shortened PTT but did not affect the prothrombin index.
- The protein partially reversed heparin's anticoagulant effect at concentrations that shortened PTT.
Conclusions:
- Alpha-acid-glycoprotein possesses procoagulant properties, notably shortening PTT.
- Its ability to counteract heparin suggests a complex interaction with the coagulation cascade.
- Further research is warranted to explore its potential role in cancer-associated coagulation disorders.
Related Concept Videos
02:45Blood Transfusion and Agglutination
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
01:06Coagulation
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:09Coagulation
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...